<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Nolan ST</submitter><funding>NIAID NIH HHS</funding><pagination>e13773</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2966435</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(10)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>M. bovis Bacille Calmette-Guérin (BCG), currently the only available vaccine against tuberculosis (TB), fails to adequately protect individuals from active and latent TB infection. New vaccines are desperately needed to decrease the worldwide burden of TB.&lt;h4>Methods and findings&lt;/h4>We created a recombinant strain of BCG that overproduces an L,D-transpeptidase in order to alter the bacterial peptidoglycan layer and consequently increase the ability of this immunogen to protect against virulent M. tuberculosis (Mtb). We demonstrate that this novel recombinant BCG protects mice against virulent Mtb at least as well as control BCG, as measured by its ability to reduce bacterial burden in lungs and spleen, reduce lung histopathology, and prolong survival. A nutrient starved</pubmed_abstract><journal>PloS one</journal><pubmed_title>Protective efficacy of BCG overexpressing an L,D-transpeptidase against M. tuberculosis infection.</pubmed_title><pmcid>PMC2966435</pmcid><funding_grant_id>R56 AI087749</funding_grant_id><pubmed_authors>Lamichhane G</pubmed_authors><pubmed_authors>Nolan ST</pubmed_authors></additional><is_claimable>false</is_claimable><name>Protective efficacy of BCG overexpressing an L,D-transpeptidase against M. tuberculosis infection.</name><description>&lt;h4>Background&lt;/h4>M. bovis Bacille Calmette-Guérin (BCG), currently the only available vaccine against tuberculosis (TB), fails to adequately protect individuals from active and latent TB infection. New vaccines are desperately needed to decrease the worldwide burden of TB.&lt;h4>Methods and findings&lt;/h4>We created a recombinant strain of BCG that overproduces an L,D-transpeptidase in order to alter the bacterial peptidoglycan layer and consequently increase the ability of this immunogen to protect against virulent M. tuberculosis (Mtb). We demonstrate that this novel recombinant BCG protects mice against virulent Mtb at least as well as control BCG, as measured by its ability to reduce bacterial burden in lungs and spleen, reduce lung histopathology, and prolong survival. A nutrient starved</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Oct</publication><modification>2025-04-05T00:26:39.58Z</modification><creation>2019-03-26T23:09:05Z</creation></dates><accession>S-EPMC2966435</accession><cross_references><pubmed>21048936</pubmed><doi>10.1371/journal.pone.0013773</doi></cross_references></HashMap>